Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer

NCT00216073 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Lack of patient accrual

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Trastuzumab

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]